// App-Quantinova.ai

P150 : The Triptryium wilfordii derivative celastrol has anti-fibrotic effects in systemic sclerosis

Researchers

Presenter

  • Andrew Leask

Principal Investigators

  • Richard J Stratton

  • Shiwen Xu

  • Pratyusha Chitturi

Medical Centers

  • University of Saskatchewan, Saskatoon, SK, Canada

  • Academic Neonatology, University College London, London, United Kingdom

Locations

  • Canada

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Scleroderma

Biomarkers

  • Nucleoside diphosphate kinase A

Drug/Treatment

  • celastrol

  • Bleomycin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved